These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29338726)

  • 41. Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
    Barber BE; Abd-Rahman AN; Webster R; Potter AJ; Llewellyn S; Marquart L; Sahai N; Leelasena I; Birrell GW; Edstein MD; Shanks GD; Wesche D; Moehrle JJ; McCarthy JS
    Clin Infect Dis; 2023 Jun; 76(11):1919-1927. PubMed ID: 36795050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Life-threatening Plasmodium falciparum parasitemia, in an infant returning from the tropics].
    Gérardin P; Dorkenoo A; Cremer R; Chenaud M; Camus D; Leclerc F
    Arch Pediatr; 2002 Dec; 9(12):1260-3. PubMed ID: 12536109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular evidence for relapse of an imported Plasmodium ovale wallikeri infection.
    Veletzky L; Groger M; Lagler H; Walochnik J; Auer H; Fuehrer HP; Ramharter M
    Malar J; 2018 Feb; 17(1):78. PubMed ID: 29426330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
    Fanello CI; Karema C; van Doren W; Van Overmeir C; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):344-50. PubMed ID: 17005222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children.
    Sowunmi A; Gbotosho GO; Happi CT; Fateye BA
    Acta Trop; 2010 Feb; 113(2):155-61. PubMed ID: 19874795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study.
    Hatz C; Soto J; Nothdurft HD; Zoller T; Weitzel T; Loutan L; Bricaire F; Gay F; Burchard GD; Andriano K; Lefèvre G; De Palacios PI; Genton B
    Am J Trop Med Hyg; 2008 Feb; 78(2):241-7. PubMed ID: 18256423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia.
    Sutanto I; Suprianto S; Widiaty A; Rukmiyati ; Ruckert P; von Bethmann A; de Monbrison F; Picot S; Laihad F; Baird JK
    Acta Med Indones; 2012 Jul; 44(3):187-92. PubMed ID: 22983072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics and Severity of Disease among 100 Cases of Imported Malaria Seen at a U.S. University Hospital, 2000-2017.
    Akselrod H; Swierzbinski MJ; Zheng Z; Keiser J; Parenti DM; Simon GL
    Am J Trop Med Hyg; 2018 Dec; 99(6):1511-1517. PubMed ID: 30350769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon.
    Dejon-Agobé JC; Zinsou JF; Honkpehedji YJ; Ateba-Ngoa U; Edoa JR; Adegbite BR; Mombo-Ngoma G; Agnandji ST; Ramharter M; Kremsner PG; Lell B; Grobusch MP; Adegnika AA
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006663. PubMed ID: 30080853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d'Ivoire.
    Toure OA; Kouame MG; Didier YJ; Berenger AA; Djerea K; Genevieve GO; Penali LK
    Trop Med Int Health; 2011 Mar; 16(3):290-7. PubMed ID: 21214690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malaria in a tertiary hospital in Singapore--clinical presentation, treatment and outcome: an eleven year retrospective review.
    Chung SJ; Low JG; Wijaya L
    Travel Med Infect Dis; 2014; 12(6 Pt B):738-44. PubMed ID: 25467088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmodium knowlesi in a traveller returning to New Zealand.
    Hoosen A; Shaw MT
    Travel Med Infect Dis; 2011 May; 9(3):144-8. PubMed ID: 21481643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Diallo A; Kone M; Coulibaly M; Diawara SI; Guindo O; Maiga H; Niambele MB; Sissoko M; Dicko A; Djimde A; Doumbo OK
    Am J Trop Med Hyg; 2008 Nov; 79(5):655-61. PubMed ID: 18981499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artemether-lumefantrine for treating uncomplicated falciparum malaria.
    Omari AA; Preston C; Garner P
    Cochrane Database Syst Rev; 2002; (3):CD003125. PubMed ID: 12137676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.
    Denis MB; Tsuyuoka R; Lim P; Lindegardh N; Yi P; Top SN; Socheat D; Fandeur T; Annerberg A; Christophel EM; Ringwald P
    Trop Med Int Health; 2006 Dec; 11(12):1800-7. PubMed ID: 17176344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial.
    Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L;
    Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.